By collaboration, I mean that another company such as Roche, Merck, Pfizer, BMS (with the latest hire by Ariad today in the press release) or Gilead takes an equity stake in the company, something that Berger referred to in one of the investor conferences last year. It will help solve cash problems while keeping Ariad "independent" as many on this board want to see.
It could also mean that there can be an arrangement to market Brigatinib by a Big Pharma before an all-out buyout.
News 
Market Data 
Discover 
